Abstract:FGF9 induced cell proliferation, EMT, migration, and invasion of mouse Lewis lung cancer (LLC) cells, in vitro.FGF9 interacted with FGFR1 and activated FAK, AKT, and ERK/MAPK signal pathways, induced the expression of EMT key proteins (N-cadherin, vimentin, snail, MMP2, MMP3 and MMP13) and reduced the expression of E-cadherin.FGF9 promoted liver metastasis of subcutaneous inoculated LLC tumor with tumor growth, angiogenesis, EMT and M2-macrophage infiltration in the tumor microenvironment.The FGF9/LLC syngeneic animal model provides a useful tool for the mechanism studies of liver metastasis which is the worst prognostic factor for lung cancer patients with distant organ metastasis.Fibroblast growth factors 9 (FGF9) modulates cell proliferation, differentiation and motility for development and repair in normal cells. Abnormal activation of FGF9 signaling is associated with tumor progression in many cancers. Also, FGF9 may be an unfavorable prognostic indicator for non-small cell lung cancer patients. However, the effects and mechanisms of FGF9 in lung cancer remain elusive. In this study, we investigated the FGF9-induced effects and signal activation profiles in mouse Lewis lung carcinoma (LLC) in vitro and in vivo. Our results demonstrated that FGF9 significantly induced cell proliferation and epithelial-to-mesenchymal transition (EMT) phenomena (migration and invasion) in LLC cells. Mechanism-wise, FGF9 interacted with FGFR1 and activated FAK, AKT, and ERK/MAPK signal pathways, induced the expression of EMT key proteins (N-cadherin, vimentin, snail, MMP2, MMP3 and MMP13), and reduced the expression of E-cadherin. Moreover, in the allograft mouse model, intratumor injection of FGF9 to LLC-tumor bearing C57BL/6 mice enhanced LLC tumor growth which were the results of increased Ki67 expression and decreased cleaved caspase-3 expression compared to control groups. Furthermore, we have a novel finding that FGF9 promoted liver metastasis of subcutaneous inoculated LLC tumor with angiogenesis, EMT and M2-macrophage infiltration in the tumor microenvironment. In conclusion, FGF9 activated FAK, AKT, and ERK signaling through FGFR1 with induction of EMT to stimulate LLC tumorigenesis and hepatic metastasis. This novel FGF9/LLC allograft animal model may therefore be useful to study the mechanism of liver metastasis which is the worst prognostic factor for lung cancer patients with distant organ metastasis.

Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases

Abstract 431: Conversion of Tumor Microvessels into a Hierarchical and Vasoreactive Network, and Suppression of Metastases, by Fibroblast Growth Factor 9

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

Supplementary Figure 1 from Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor Α Signaling is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma

Dual Roles of Endothelial FGF-2–FGFR1–PDGF-BB and Perivascular FGF-2–FGFR2–PDGFRβ Signaling Pathways in Tumor Vascular Remodeling

Vascular Endothelial Growth Factor-Dependent Spatiotemporal Dual Roles of Placental Growth Factor in Modulation of Angiogenesis and Tumor Growth

FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinoma

Fibrotic Microenvironment Promotes the Metastatic Seeding of Tumor Cells Via Activating the Fibronectin 1/secreted Phosphoprotein 1-Integrin Signaling

Endothelial miR-30c suppresses tumor growth via inhibition of TGF-&bgr;–induced Serpine1

Role of FGF10 on tumorigenesis by MS-K.

Paracrine Signaling by Platelet-Derived Growth Factor-Cc Promotes Tumor Growth by Recruitment of Cancer-Associated Fibroblasts

PDGF-D Improves Drug Delivery and Efficacy Via Vascular Normalization, but Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer.

Pericyte-fibroblast Transition Promotes Tumor Growth and Metastasis.

PLGF Regulates Crosstalk Between Non-Small Cell Lung Cancer Cells and Tumor-Associated Macrophages in Cancer Vascularization and Growth

Tumor-derived Vascular Endothelial Growth Factor (Vegf)-a Facilitates Tumor Metastasis Through the VEGF-VEGFR1 Signaling Pathway.

Responses of Vascular Endothelial Cells to Angiogenic Signaling Are Important for Tumor Cell Survival.

Effects of modulation of basic fibroblast growth factor on tumor growth in vivo

FGF9/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer

Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth

Vascular endothelial growth factor B coordinates metastasis of non-small cell lung cancer

Tumor Cell-Derived Placental Growth Factor Sensitizes Antiangiogenic and Antitumor Effects of Anti-Vegf Drugs